Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?

Emily J. Gallagher; Derek Leroith

doi:10.1016/j.cmet.2013.05.006

Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?

Emily J. Gallagher, Derek Leroith

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Abstract

A polymorphism in the fibroblast growth factor receptor 4 gene has been associated with cancer progression and treatment resistance and is now reported to increase insulin secretion, providing a possible genetic link between hyperinsulinemia and cancer (Ezzat et al., 2013).

Original language	English
Pages (from-to)	808-809
Number of pages	2
Journal	Cell Metabolism
Volume	17
Issue number	6
DOIs	https://doi.org/10.1016/j.cmet.2013.05.006
State	Published - 4 Jun 2013

Access to Document

10.1016/j.cmet.2013.05.006

Cite this

@article{3fd5dd595b8544628b57b85fb985d246,

title = "Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?",

abstract = "A polymorphism in the fibroblast growth factor receptor 4 gene has been associated with cancer progression and treatment resistance and is now reported to increase insulin secretion, providing a possible genetic link between hyperinsulinemia and cancer (Ezzat et al., 2013).",

author = "Gallagher, {Emily J.} and Derek Leroith",

year = "2013",

month = jun,

day = "4",

doi = "10.1016/j.cmet.2013.05.006",

language = "English",

volume = "17",

pages = "808--809",

journal = "Cell Metabolism",

issn = "1550-4131",